National Pharmaceutical Law Firm Helping Potential Dialysis Injury Victims

The law firm of Henry Spiegel Milling LLP is currently warning dialysis patients of the Class I FDA Recall for GranuFlo and NaturaLyte, and representing potential injury victims and their families.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
GranuFlo injury attorney
What’s most disturbing is that they warned their own clinics, but did nothing to prevent injuries and deaths in clinics they didn’t own or operate...

Atlanta, Georgia (PRWEB) August 22, 2012

Henry Spiegel Milling LLP, a nationally recognized products liability law firm, is currently warning patients of the potential dangers associated with the dialysis products, GranuFlo and NaturaLyte. The firm is also representing injury victims and families that may have lost a loved one due to dialysis treatment.

Major developments started in early November of 2011, when the drug maker Fresenius Medical Care (FMC) sent a memo to its own dialysis clinics warning of significant dangers associated with GranuFlo and NaturaLyte. According to a June 2012 New York Times article, Fresenius chose at that time however not to notify the public or U.S. Food and Drug Administration that in 2010 over 940 people suffered cardiac arrest during dialysis treatments in their facilities. (It's estimated that at that time over 100,000 patients were receiving treatment with Fresenius products at non-FMC facilities.)

Experienced pharmaceutical litigation attorney R. Clay Milling believes this inaction by Fresenius is unacceptable from both a legal and ethical perspective. “What’s most disturbing is that they warned their own clinics, but did nothing to prevent injuries and deaths in clinics they didn’t own or operate, even though they knew their products were being used there.”

In late March of 2012, five months after FMC's internal memo, the company sent an Urgent Product Notification to their clinics and customers warning about the dangers of GranuFlo and NaturaLyte. The FDA also issued a Class I recall for NaturaLyte and GranuFlo Acid Concentrate. Class I drug recalls are the most serious, and involve situations in which there is a reasonable probability that use of a product will cause serious adverse health consequences or death.

If you or a loved one has been injured or suffered cardiac arrest or stroke during treatment for kidney failure, contact the dialysis injury attorneys at Henry Spiegel Milling LLP today at (866) 959-3877 or email at info@hsm-law.com. Additional information about GranuFlo lawsuits or the NaturaLyte recall is also available at http://www.dialysisheartattackattorney.com.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn Contact's Google Plus